Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Hüttmann

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Prognostic significance of molecular remission in follicular lymphomaUlrich Dührsen, Andreas Hüttmann, Jan Dürig
British Journal of Haematology|July 23, 2009
Porphyria cutanea tardaSandra Christoph, Andreas Hüttmann, Ulrich Dührsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2018
Reply to H.J.A Adams et al and C. GisselbrechtUlrich Dührsen, Stefan Müller, Jan Rekowski, et al.
European Journal of Haematology|November 25, 2018
Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvementMaria Sakarou, Lewin Eisele, Ulrich Dührsen, et al.
Oncology Research and Treatment|September 20, 2019
Treatment Outcome in Patients with Primary or Secondary Transformed Indolent B-Cell LymphomasSedat Demirdas, Jörg Hense, Ulrich Dührsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Pitfalls of interim positron emission tomography scanning in diffuse large B-cell lymphomaAndreas Hüttmann, Stefan Müller, Karl-Heinz Jöckel, et al.
Leukemia & Lymphoma|October 30, 2009
Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas--the PETAL trialUlrich Dührsen, Andreas Hüttmann, Karl-Heinz Jöckel, et al.
Mycoses|February 14, 2023
Neutropenia-related aspergillosis in non-transplant haematological patients hospitalised under ambient air versus purified air conditionsChristina Friese, Katharina Breuckmann, Andreas Hüttmann, et al.
Blood|April 18, 2009
Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin diseaseAlexander Röth, Andreas Hüttmann, Russell P Rother, et al.
Transfusion|August 29, 2006
Rapid succession of peripheral blood progenitor cell mobilization cycles in patients with chronic heart failure: effects on the hematopoietic systemAndreas Hüttmann, Achim Gutersohn, Richard Noppeney, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Prognostic significance of molecular remission in follicular lymphomaUlrich Dührsen, Andreas Hüttmann, Jan Dürig
British Journal of Haematology|July 23, 2009
Porphyria cutanea tardaSandra Christoph, Andreas Hüttmann, Ulrich Dührsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2018
Reply to H.J.A Adams et al and C. GisselbrechtUlrich Dührsen, Stefan Müller, Jan Rekowski, et al.
European Journal of Haematology|November 25, 2018
Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvementMaria Sakarou, Lewin Eisele, Ulrich Dührsen, et al.
Oncology Research and Treatment|September 20, 2019
Treatment Outcome in Patients with Primary or Secondary Transformed Indolent B-Cell LymphomasSedat Demirdas, Jörg Hense, Ulrich Dührsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Pitfalls of interim positron emission tomography scanning in diffuse large B-cell lymphomaAndreas Hüttmann, Stefan Müller, Karl-Heinz Jöckel, et al.
Leukemia & Lymphoma|October 30, 2009
Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas--the PETAL trialUlrich Dührsen, Andreas Hüttmann, Karl-Heinz Jöckel, et al.
Mycoses|February 14, 2023
Neutropenia-related aspergillosis in non-transplant haematological patients hospitalised under ambient air versus purified air conditionsChristina Friese, Katharina Breuckmann, Andreas Hüttmann, et al.
Blood|April 18, 2009
Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin diseaseAlexander Röth, Andreas Hüttmann, Russell P Rother, et al.
Transfusion|August 29, 2006
Rapid succession of peripheral blood progenitor cell mobilization cycles in patients with chronic heart failure: effects on the hematopoietic systemAndreas Hüttmann, Achim Gutersohn, Richard Noppeney, et al.
Pageof 9